Primary biliary cirrhosis epidemiology and demographics: Difference between revisions
Created page with "__NOTOC__ {{CMG}} {{Primary biliary cirrhosis}} ==References== {{reflist|2}} {{WH}} {{WS}} Category:Gastroenterology Category:Hepatology [[Category:Autoimmune dise..." |
No edit summary |
||
| Line 2: | Line 2: | ||
{{CMG}} | {{CMG}} | ||
{{Primary biliary cirrhosis}} | {{Primary biliary cirrhosis}} | ||
==Epidemiology and Demographics== | |||
===Gender=== | |||
The female:male ratio is at least 9:1. | |||
===Prevalence=== | |||
In some areas of the US and UK the prevalence is estimated to be as high as 1 in 4000. This is much more common than in South America or Africa, which may be due to better recognition in the US and UK. First-degree relatives may have as much as a 500 times increase in prevalence, but there is debate if this risk is greater in the same generation relatives or the one that follows. | |||
==References== | ==References== | ||
| Line 14: | Line 18: | ||
[[Category:Autoimmune diseases]] | [[Category:Autoimmune diseases]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Needs overview]] | |||
[[Category:Needs | |||
Revision as of 19:37, 16 April 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
Primary Biliary Cirrhosis Microchapters |
|
Differentiating Primary Biliary Cirrhosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Primary biliary cirrhosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Primary biliary cirrhosis epidemiology and demographics |
|
FDA on Primary biliary cirrhosis epidemiology and demographics |
|
CDC on Primary biliary cirrhosis epidemiology and demographics |
|
Primary biliary cirrhosis epidemiology and demographics in the news |
|
Blogs on Primary biliary cirrhosis epidemiology and demographics |
|
Risk calculators and risk factors for Primary biliary cirrhosis epidemiology and demographics |
Epidemiology and Demographics
Gender
The female:male ratio is at least 9:1.
Prevalence
In some areas of the US and UK the prevalence is estimated to be as high as 1 in 4000. This is much more common than in South America or Africa, which may be due to better recognition in the US and UK. First-degree relatives may have as much as a 500 times increase in prevalence, but there is debate if this risk is greater in the same generation relatives or the one that follows.